Home

Aarti Drugs Ltd PE Ratio

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

PE

22

Last updated on: Apr 25, 2025

Key Highlights

  • The P/E Ratio of Aarti Drugs Ltd is 22 as of 25 Apr 15:30 PM .
  • The P/E Ratio of Aarti Drugs Ltd changed from 8.3 on March 2020 to 23.3 on March 2024 . This represents a CAGR of 22.93% over 5 years.
  • The Latest Trading Price of Aarti Drugs Ltd is ₹ 350.7 as of 25 Apr 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 26.1. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Aarti Drugs Ltd

No data available

Company Fundamentals for Aarti Drugs Ltd

Image

Aarti Drugs Ltd

NSE: AARTIDRUGS

Share Price

₹ 350.7

-15.05 (-4.11%)

stock direction

Last updated on: Apr 25, 2025

Market Price of Aarti Drugs Ltd

1M

1Y

3Y

5Y

Monitoring Aarti Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
24 Apr 2025365.75
23 Apr 2025365
22 Apr 2025359.2
21 Apr 2025362.15
17 Apr 2025357.45
16 Apr 2025358.25
15 Apr 2025355.8
11 Apr 2025329.05
09 Apr 2025322.2
08 Apr 2025330.65

SWOT Analysis Of Aarti Drugs Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Aarti Drugs Ltd

Asset Value vs Market Value of Aarti Drugs Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Aarti Drugs Ltd3362
Sun Pharmaceutical Industries Ltd432960
Divis Laboratories Ltd165003
Cipla Ltd125286
Torrent Pharmaceuticals Ltd112503
Mankind Pharma Ltd107386

PE Ratio of Aarti Drugs Ltd Explained

3362

Market cap

152

Earnings

22.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Aarti Drugs Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Aarti Drugs Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Aarti Drugs Ltd

No data available

* All values are in %

About Aarti Drugs Ltd

  • Aarti Drugs Limited (ADL), incorporated in September, 1984 is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals.
  • The Company operates as part of the Aarti Group, a conglomerate with a net worth of USD 900 million.
  • With over 50 compounds for Antibiotics, Anti Protozoal, Anti-Inflammatory, Anti-diabetic, Anti Fungal and Cardioprotectant therapeutic segments, the Company has emerged as market leader in APIs.
  • It has a wholly-owned subsidiary called Pinnacle Life Science Private Limited which operates in the field of manufacturing formulations. The Company has two R&D divisions, one in Tarapur and the other in Turbhe, Maharashtra.
  • It has 3 subsidiaries, namely, Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited and Pinnacle Chile SpA (foreign subsidiary).

Aarti Drugs Ltd News Hub

Aarti Drugs hit 52-week high as board OKs Rs 60-cr share buyback

The buyback price fixed at Rs 900 per equity share, representing a 59.66% premium to Friday's closin

Read more

26 Aug 24

Aarti Drugs to consider buyback

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 26 August 2024. Powered

Read more

22 Aug 24

Aarti Drugs soars on share buyback proposal

The announcement was made after market hours yesterday. Aarti Drugs forms part of $6 Billion Aarti G

Read more

22 Aug 24

Board of Aarti Drugs approves buyback of shares up to Rs 59.85 cr

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,00

Read more

26 Aug 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Aarti Drugs Ltd

What is the current PE Ratio of Aarti Drugs Ltd?

The Current PE Ratio of Aarti Drugs Ltd is 22.02 as on 25 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 25 Apr 2025.

What was the PE Ratio of Aarti Drugs Ltd last year?

The PE Ratio of Aarti Drugs Ltd was 18.81 last year, now the PE ratio is 22.02, showing a year-on-year growth of 17.1%.

What does the PE Ratio of Aarti Drugs Ltd indicate about its stock?

The PE Ratio of Aarti Drugs Ltd is 22.02. This ratio indicates that investors are willing to pay 22.02 times the earnings per share for each share of Aarti Drugs Ltd.

What is the PE Ratio Growth of Aarti Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Aarti Drugs Ltd grew by 17.1% whereas, the EPS ratio grew by 6.0.

How does the PE ratio of Aarti Drugs Ltd compare to industry peers?

The PE ratio of Aarti Drugs Ltd PE Ratio can indicate whether it is overvalued or undervalued compared to competitors in the same industry. A lower PE ratio may suggest an undervalued stock, while a higher PE ratio could indicate premium pricing.

Is a high PE ratio for Aarti Drugs Ltd PE Ratio good or bad?

A high PE ratio may indicate strong future growth expectations, but it can also suggest overvaluation. It is best to compare it with industry averages and historical trends of Aarti Drugs Ltd PE Ratio.

What factors influence the PE ratio of Aarti Drugs Ltd PE Ratio?

The PE ratio of Aarti Drugs Ltd PE Ratio is influenced by factors such as earnings growth, investor sentiment, macroeconomic conditions, and sector trends.

How often does the PE ratio of Aarti Drugs Ltd PE Ratio change?

The PE ratio changes as the share price or earnings of Aarti Drugs Ltd PE Ratio fluctuate, and it is updated whenever there is a significant movement in either of these factors.

Where can I find the latest PE ratio of Aarti Drugs Ltd PE Ratio?

You can check the latest PE ratio of Aarti Drugs Ltd PE Ratio on BlinkX Website above or any other stock market platforms, or at the company’s official website.

What is a good PE ratio for Aarti Drugs Ltd PE Ratio?

A "good" PE ratio depends on industry standards and market conditions. It is advisable to compare Aarti Drugs Ltd PE ratio with its historical average and competitors.

Can the PE ratio of Aarti Drugs Ltd PE Ratio predict future stock performance?

While the Aarti Drugs Ltd PE ratio is a useful indicator of valuation, it should be used alongside other financial metrics and market analysis to make informed investment decisions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions